Hepatocellular carcinoma: Therapy and prevention

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 47

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 21, 2005; 11(47): 7391-7400
Published online Dec 21, 2005. doi: 10.3748/wjg.v11.i47.7391

Table 3 Drugs evaluated in clinical trials for the treatment of patients with HCC

5-Fluorouracil

Capecitabine

Doxorubicin

Epirubicin

Etoposide

Cisplatin

Gemcitabine

Mitoxantrone

Interferon alpha

Megestrol acetate

Tamoxifen

Octreotide

Thalidomide

Thymophysin

α-1-thymosin

Citation: Blum HE. Hepatocellular carcinoma: Therapy and prevention. World J Gastroenterol 2005; 11(47): 7391-7400
URL: https://www.wjgnet.com/1007-9327/full/v11/i47/7391.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i47.7391

Blum HE. Hepatocellular carcinoma: Therapy and prevention. World J Gastroenterol 2005; 11(47): 7391-7400 [PMID: 16437707 DOI: 10.3748/wjg.v11.i47.7391]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.